Assessment of Digoxin-Specific Fab Fragment Dosages in Digoxin Poisoning.
Digoxin poisoning still remains a common cause of morbidity and mortality. Fortunately, digoxin-specific Fab fragments are commercially available as an antidote. However, these Fab fragments are several thousand dollars per vial. There is a standardized formula to calculate appropriate Fab fragment dosage based on the serum digoxin concentration. This can greatly reduce the amount of Fab fragment administered. There is also an empiric dosing guideline recommending 6-10 vials be given; however, this may result in higher amounts of Fab fragments being administered than required. We performed this study to assess the amounts of digoxin-specific Fab fragments administered in the treatment of digoxin poisonings recorded in a poison control system database from January 1, 2000, to December 31, 2009, in which digoxin serum concentrations were available. This was a retrospective study of 278 patients, 107 with acute poisonings (group A) and 171 following chronic poisoning (group B). In group A, the calculated Fab dose was higher than the calculated dose based on available concentrations in 39 (36%) of group A and 15 (9%) of group B patients. The average wholesale price cost of the excessive dosages ranged from $4818 to as high as $50,589 per patient. Our data suggests that clinician education on digoxin poisoning and the use of the standardized formula to calculate the Fab dose may decrease over utilization and decrease costs associated with the administration of digoxin-specific Fab fragments in the treatment of digoxin poisonings.
1Department of Emergency Medicine, Section of Toxicology, Keck School of Medicine, University of Southern California, Los Angeles, CA; 2California Poison Control System-San Diego Division, San Diego, CA; and 3Department of Surgery, UCSF Fresno, Fresno, CA.
Sean Patrick
SP
Nordt
Richard F
RF
Clark
Carol
C
Machado
F Lee
FL
Cantrell
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D004077:Digoxin / Q000276:immunology / Q000506:poisoning*; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D007223:Infant; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors
D007140:Immunoglobulin Fab Fragments; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase